Omega Alpha SPAC
Liquidated 2022-12-27- CIK 1832010
- OMEG
- IPO 2021-01-08
- $139M trust
- 50 filings
- IPO Size
- $138M
- raised at the IPO
- Trust
- $139M
- as of 2022-09-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
50 filings over 10 quarters; violet bars carry a milestone
- 20 Q4: 2 filings
- 21 Q1: 22 filings
- 21 Q2: 1 filing
- 21 Q3: 1 filing
- 21 Q4: 1 filing
- 22 Q1: 7 filings
- 22 Q2: 1 filing
- 22 Q3: 6 filings
- 22 Q4: 3 filings
- 23 Q1: 6 filings
S-1 filed
IPO
Liquidated
- S-1 filed 20 Q4
- IPO 21 Q1
- Liquidated 22 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Omega Alpha SPAC is a blank-check company seeking a business combination, with a stated focus on healthcare and healthcare-related industries, particularly biotechnology companies in North America or Europe.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2021-01-08
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- Failed Date
- 2022-12-27
- SPAC Ticker
- OMEG
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The management team brings more than 65 years of collective life-sciences investing experience. Its leaders are senior Omega executives with healthcare investment, operational and transactional experience, supported by an investment team with a transatlantic network.